| Name |
Format |
Description |
Link |
| Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a01-eng.pdf |
| Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a01f-fra.pdf |
| Preventing the spread of extensively drug-resistant gonorrhea |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a02-eng.pdf |
| Preventing the spread of extensively drug-resistant gonorrhea |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a02f-fra.pdf |
| Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics? |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a03-eng.pdf |
| Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics? |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a03f-fra.pdf |
| Tuberculosis in Canada, 2017 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a04-eng.pdf |
| Tuberculosis in Canada, 2017 |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a04f-fra.pdf |
| Addressing reluctance to STBBI screening |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a05-eng.pdf |
| Addressing reluctance to STBBI screening |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23a05f-fra.pdf |
| CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23-eng.pdf |
| CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea |
PDF |
|
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/ccdrv45i23f-fra.pdf |
| Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-1-multidrug-resistant-extensively-drug-resistant-gonorrhea-canada.html |
| Preventing the spread of extensively drug-resistant gonorrhea |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-2-preventing-spread-drug-resistant-gonorrhea.html |
| Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics? |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-3-integrated-surveillance-address-sexually-transmitted-blood-born-syndemics.html |
| Tuberculosis in Canada, 2017 |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-4-tuberculosis-in-canada.html |
| Addressing reluctance to STBBI screening |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019/article-5-addressing-reluctance-stbbi-screening.html |
| CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea |
HTML |
|
https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-2-february-7-2019.html |
| Multidrug-resistant and extensively drug-resistant Neisseria gonorrhoeae in Canada, 2012–2016 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-1-gonorrhee-multiresistante-ultraresistante-canada.html |
| Preventing the spread of extensively drug-resistant gonorrhea |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-2-prevenir-propagation-gonorrhee-ultraresistante.html |
| Do we need integrated surveillance to address sexually transmitted and blood-borne syndemics? |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-3-avons-nous-besoin-une-surveillance-integree-evaluer-syndemies-transmises-sexuellement-ang.html |
| Tuberculosis in Canada, 2017 |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-4-tuberculose-au-canada.html |
| Addressing reluctance to STBBI screening |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019/article-5-preparation-pandemie-influenza-canada-strategie-antivirale.html |
| CCDR: Volume 45-2/3, February 7, 2019: Multidrug resistant gonorrhea |
HTML |
|
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2019-45/numero-2-7-fevrier-2019.html |